Detalhe da pesquisa
1.
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler
; 26(8): 912-923, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31066634
2.
Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disability.
Eur J Neurol
; 27(11): 2225-2232, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32602573
3.
Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.
Eur J Neurol
; 25(9): 1189-1191, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29797629
4.
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
Eur J Neurol
; 25(2): 215-237, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29352526
5.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Pharmacogenomics J
; 17(4): 312-318, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27001119
6.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Eur Radiol
; 27(4): 1361-1368, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27456965
7.
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Mult Scler
; 22(7): 901-9, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26432859
8.
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
Neuroradiology
; 58(5): 467-74, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26847633
9.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
Mult Scler
; 21(6): 749-56, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25392330
10.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Mult Scler
; 21(13): 1632-43, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26432853
11.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Mult Scler
; 21(6): 780-5, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25392320
12.
Spanish consensus on the use of natalizumab (Tysabri®)-2013.
Neurologia
; 30(5): 302-14, 2015 Jun.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-24360652
13.
Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.
Clin Exp Immunol
; 175(2): 202-7, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24188195
14.
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
J Neurol Neurosurg Psychiatry
; 85(11): 1183-9, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24218527
15.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Mult Scler
; 20(7): 877-81, 2014 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24293455
16.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Mult Scler
; 20(6): 717-25, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24144876
17.
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Mult Scler
; 20(5): 577-87, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24009164
18.
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
Mult Scler
; 20(1): 72-80, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23812283
19.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
Clin Exp Immunol
; 171(3): 243-6, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23379429
20.
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
Mult Scler
; 19(5): 524-31, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22933622